InsidersTradesSigma
Track the MAYNE PHARMA GROUP LIMITED share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the authority of ASX. Market capitalisation: €265.7m. The latest transaction was disclosed on 14 August 2026 (Other). Among the most active insiders: Funicular Funds, LP. All data is free.
Analysts rate MAYNE PHARMA GROUP LIMITED Buy (bullish), based on 2 analysts. Average price target: A$4.54.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
MAYNE PHARMA GROUP LIMITED is an Australian pharmaceutical company focused on the development and commercialization of generic and branded pharmaceutical products. It is listed on the Australian Securities Exchange under the ticker MYX.